Volume 7, Issue 1

Rapid ART: Process Improvement to Escalate U = U

In this issue:

Rapid ART — initiating ART as soon as possible after HIV diagnosis — is now endorsed as standard of care in all major antiretroviral guidelines. What are the evidence-based benefits, and for which patient populations is Rapid ART most appropriate? How does it support the treatment as prevention and U = U concepts? 

These are some of the questions Dr. Jonathan Colasanti from Atlanta’s Emory University and Grady Health System addresses in this first issue of Volume 7 of eHIV Review.

Learning objectives:

  • Discuss aspects of the HIV care continuum that may or may not be improved through Rapid ART.  
  • Explain how the benefits of Rapid ART can impact a variety of populations. 


Jonathan A. Colasanti, MD, MSPH
Jonathan A. Colasanti, MD, MSPH
Associate Professor of Medicine
Emory School of Medicine
Medical Director
The Infectious Disease Program (HIV) Ponce de Leon Center,
Grady Health System
Atlanta, GA

Program Directors:

Justin Alves, RN, FNP-BC, ACRN, CARN, CNE

Nurse Educator
Boston Medical Center
Boston, MA

Matthew Spinelli, MD, MAS

Assistant Professor
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California

Ethel D. Weld, MD, PhD

Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
Baltimore, Maryland

Length of activity:

1.0 hour Physicians
1.0 contact hour Nurses

Launch date: December 16, 2021
Expiration date: December 15, 2023